Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolo Riggi

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Oncotarget|May 7, 2016
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsSeraina Faes, Anne Planche, Emilie Uldry, et al.
Molecular Cancer|December 7, 2016
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitorsSeraina Faes, Adrian P Duval, Anne Planche, et al.
Cancer Discovery|February 10, 2021
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and ProgressionDaniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2026
Differential <i>Hes1</i> activation defines neural stem cell lineage commitment and niche maintenance in embryonic and adult mouse cortexPaul Ann Riya, Rahul Jose, Vadakkath Meera, et al.
Investigative Ophthalmology & Visual Science|June 28, 2019
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways InhibitionIkram El Zaoui, Maya Bucher, Donata Rimoldi, et al.
Cell|August 29, 2017
Cancer-Specific Retargeting of BAF Complexes by a Prion-like DomainGaylor Boulay, Gabriel J Sandoval, Nicolo Riggi, et al.
Cancer Discovery|February 19, 2017
OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 MedulloblastomaGaylor Boulay, Mary E Awad, Nicolo Riggi, et al.
Cancer Research|October 14, 2025
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing SarcomaElisabet Figuerola-Bou, Carla Ríos-Astorch, Enrique Blanco, et al.
Cancer Research|December 29, 2019
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityJohannes C Melms, Sreeram Vallabhaneni, Caitlin E Mills, et al.
Cell|April 15, 2014
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cellsMario L Suvà, Esther Rheinbay, Shawn M Gillespie, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Oncotarget|May 7, 2016
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsSeraina Faes, Anne Planche, Emilie Uldry, et al.
Molecular Cancer|December 7, 2016
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitorsSeraina Faes, Adrian P Duval, Anne Planche, et al.
Cancer Discovery|February 10, 2021
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and ProgressionDaniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2026
Differential <i>Hes1</i> activation defines neural stem cell lineage commitment and niche maintenance in embryonic and adult mouse cortexPaul Ann Riya, Rahul Jose, Vadakkath Meera, et al.
Investigative Ophthalmology & Visual Science|June 28, 2019
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways InhibitionIkram El Zaoui, Maya Bucher, Donata Rimoldi, et al.
Cell|August 29, 2017
Cancer-Specific Retargeting of BAF Complexes by a Prion-like DomainGaylor Boulay, Gabriel J Sandoval, Nicolo Riggi, et al.
Cancer Discovery|February 19, 2017
OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 MedulloblastomaGaylor Boulay, Mary E Awad, Nicolo Riggi, et al.
Cancer Research|October 14, 2025
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing SarcomaElisabet Figuerola-Bou, Carla Ríos-Astorch, Enrique Blanco, et al.
Cancer Research|December 29, 2019
Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityJohannes C Melms, Sreeram Vallabhaneni, Caitlin E Mills, et al.
Cell|April 15, 2014
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cellsMario L Suvà, Esther Rheinbay, Shawn M Gillespie, et al.
Pageof 4